Drug and alcohol treatment among privately insured patients: Rate of specialty substance abuse treatment and association with cost-sharing

Drug and Alcohol Dependence

Volumn 71, Issue 2, 2003, Pages 153-159

  Stein, Bradley D ^a   Zhang, Weiying ^a  

^a RAND CORPORATION   (United States)

Author keywords

Copayment; Cost sharing; Drug and alcohol treatment; Insurance; Managed care; Residential treatment

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG DEPENDENCE TREATMENT; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL SPECIALIST; OUTPATIENT; PATIENT; POPULATION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; SUBSTANCE ABUSE;

EID: 0142043817     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00091-7     Document Type: Article

References (40)

1. Adams W.L., Yuan Z., Barboriak J.J., Rimm A.A. Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States. JAMA. 270:1993;1222-1225.
2. Anglin M.D., Hser Y. Treatment of drug abuse. Tonry M., Wilson J.Q. Drugs and Crime. 1990;393-458 University of Chicago Press, Chicago, IL.
3. Buck J.A., Teich J.L., Umland B., Stein M. Behavioral health benefits in employer-sponsored health plans, 1997. Health Aff. 18:1999;67-78.
4. Califano J.A. Substance abuse and addiction - the need to know. Am. J. Public Health. 88:1998;9-11.
5. Callahan J.J., Shepard D.S., Beinecke R.H., Larson M.J., Cavanaugh D. Mental health/substance abuse treatment in managed care: the Massachusetts Medicaid experience. Health Aff. 14:1995;173-184.
6. Chang C.F., Kiser L.J., Bailey J.E., Martins M., Gibson W.C., Schaberg K.A., Mirvis D.M., Applegate W.B. Tennessee's failed managed care program for mental health and substance abuse services. JAMA. 279:1998;864-869.
7. Druss B.G., Allen H.M. Jr., Bruce M.L. Physical health, depressive symptoms, and managed care enrollment. Am. J. Psychiatry. 155:1998;878-882.
8. Epstein J., Gfoerer J. Changes Affecting NHSDA Estimates of Treatment Need for 1993-1996. 1998;Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Washington DC.
9. Garnick D.W., Hodgkin D., Horgan C.M. Selecting data sources for substance abuse services research. J. Subst. Abuse Treat. 22:2002;11-22.
10. Garnick, D.W., Lee, M.T., Chalk, M., Gastfriend, D., Horgan, C.M., McCorry, F., McLellan, A.T., Merrick, E.L., 2002b. Establishing the Feasibility of Performance Measures for Alcohol and other Drugs Working Paper, Schneider Institute for Health Policy, Heller School for Policy and Management, Brandeis University.
11. Gerstein D.R., Harwood H.J. Treating Drug Problems: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems. 1990;National Academy Press, Washington, DC.
12. Gerstein D.R., Johnson R.A., Harwood H.J., Fountain D., Suter N., Malloy K. Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA) General Report. 1994;Department of Alcohol and Drug Programs, Sacramento, CA.
13. Goldman W., McCulloch J., Sturm R. Costs and utilization of mental health services before and after managed care. Health Aff. 17:1998;40-52.
14. Horgan C.M., Merrick E.L. Financing of substance abuse treatment services. Recent Dev. Alcohol. 15:2001;229-252.
15. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug Abuse Treatment: A National Study of Effectiveness. 1989;University of North Carolina Press, Chapel Hill, NC.
16. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 11:1997;261-278.
17. Jensen G.A., Morrisey M.A., Gaffney S., Liston D.K. The new dominance of managed care: insurance trends in the 1990s. Health Aff. 16:1997;125-136.
18. Keeler E.B., Manning W.G., Wells K.B. The demand for episodes of mental health services. J. Health Econ. 7:1988;369-392.
19. Lo Sasso A.T., Lyons J.S. The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence. Psychiatry Serv. 53:2002;1605-1611.
20. Long C.G., Williams M., Hollin C.R. Treating alcohol problems: a study of programme effectiveness and cost effectiveness according to length and delivery of treatment. Addiction. 93:1998;561-571.
21. Ma C.A., McGuire T.G. Costs and incentives in a behavioral health carve-out. Health Aff. 17:1998;53-69.
22. Mark T.L., Coffey R.M., King E., Harwood H., McKusick D., Genuardi J., Dilonardo J., Buck J.A. Spending on mental health and substance abuse treatment, 1987-1997. Health Aff. 19:2000;108-120.
23. McCorry F., Garnick D.W., Bartlett J., Cotter F., Chalk M. Developing performance measures for alcohol and other drug services in managed care plans. Joint Comm. J. Qual. Im. 26:2000;633-643.
24. McLellan, A.T., Meyers, K., Belding, M., Levine, M., Gould, F., Bencivengo, M., 1998. Effects of managed care on outcomes of publicly treated substance abuse patients. Abstract Book/Association for Health Services Research, vol. 14, pp. 162-163.
25. Morrisey M.A., Jensen G.A. Employer-sponsored insurance coverage for alcoholism and drug-abuse treatments. J. Stud. Alcohol. 49:1988;456-461.
26. Office of National Drug Control Policy, 1999. National Drug Control Strategy, 1999. National Institute of Justice, Washington, DC.
27. Oss M.E., Clary J.H. Managed Behavioral Health Marketshare in the United States, 1998-1999. 1999;Open Minds, Gettysburg, PA.
28. Schoenbaum M., Zhang W., Sturm R. Costs and utilization of substance abuse care in a privately insured population under managed care. Psychiatry Serv. 49:1998;1573-1578.
29. Simpson D.D., Joe G.W., Broome K.M. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry. 59:2002;538-544.
30. Solano, P.L., 1997. Financing of Drug Treatment Services. 2000 NIDA Resource Center for Health Services Research.
31. Stata Corporation, 1997. STATA STATISTICAL Software: Release 5.0. Stata Corporation, College Station, TX.
32. Stein B.D., Reardon E., Sturm R. Substance abuse service utilization under managed care: HMOs versus carve-out plans. J. Behav. Health Serv. Res. 26:1999;451-456.
33. Stein B., Orlando M., Sturm R. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care. Psychiatry Serv. 51:2000;195-198.
34. Sturm R. How expensive is unlimited mental health care coverage under managed care? JAMA. 278:1997;1533-1537.
35. Sturm R. Tracking changes in behavioral health services: how have carve-outs changed care? J. Behav. Health Serv. Res. 26:1999;360-371.
36. Sturm R., Jackson C.A., Meredith L.S., Yip W., Manning W.G., Rogers W.H., Wells K.B. Mental health care utilization in prepaid and fee-for-service plans among depressed patients in the Medical Outcomes Study. Health Serv. Res. 30:1995;319-340.
37. Sturm R., Zhang W., Schoenbaum M. How expensive are unlimited substance abuse benefits under managed care? J. Behav. Health Serv. Res. 26:1999;203-210.
38. Substance Abuse and Mental Health Services Administration, 2001. Summary of Findings from the 2000 National Household Survey on Drug Abuse. Office of Applied Studies, NHSDA, Rockville, MD.
39. US Department of Labor Bureau of Labor Statistics, 1998. Employee Benefits in Medium and Large Private Establishments, 1995. Washington DC.
40. Woodward A., Epstein J., Gfroerer J., Melnick D., Thoreson R., Willson D. The drug abuse treatment gap: recent estimates. Health Care Financ. Rev. 18:1997;5-17.